Table 2.
CVD Event | ESRD Event | Death Event | |
---|---|---|---|
Age, per 10-y older | 1.18 (1.04–1.32) | 0.76 (0.70–0.83) | 1.77 (1.41–2.24) |
Male sex | 0.99 (0.78–1.25) | 1.22 (1.01–1.49) | 1.15 (0.77–1.71) |
Race | |||
Black | 0.90 (0.71–1.14) | 1.16 (0.93–1.43) | 1.69 (1.09–2.62) |
Other | 0.83 (0.54–1.28) | 1.39 (0.99–1.96) | 0.82 (0.38–1.76) |
White | 1.00 (reference | 1.00 (reference | 1.00 (reference |
Hispanic vs non-Hispanic ethnicity | 0.89 (0.60–1.32) | 0.80 (0.58–1.11) | 2.23 (1.20–4.15) |
eGFR, per 5-ml/min/1.73 m2 higher | 0.96 (0.83–1.11) | 0.76 (0.66–0.86) | 0.88 (0.69–1.12) |
Urine PCR, per 2-fold higher | 0.98 (0.92–1.03) | 1.34 (1.27–1.41) | 0.89 (0.82–0.98) |
BMI category | |||
25–29.9 kg/m2 | 1.07 (0.73–1.58) | 0.98 (0.74–1.29) | 0.80 (0.43–1.50) |
30–35 kg/m2 | 1.31 (0.90–1.90) | 0.84 (0.62–1.14) | 0.96 (0.53–1.73) |
>35 kg/m2 | 1.33 (0.92–1.92) | 0.76 (0.57–1.03) | 1.01 (0.56–1.82) |
25 kg/m2 | 1.00 (reference | 1.00 (reference | 1.00 (reference |
Diabetes | 1.69 (1.31–2.18) | 0.82 (0.67–1.01) | 1.17 (0.77–1.78) |
SBP, per 10–mm Hg higher | 1.08 (1.03–1.14) | 1.03 (0.99–1.08) | 0.92 (0.82–1.02) |
Any CVD History | 2.16 (1.70–2.75) | 0.65 (0.52–0.82) | 1.04 (0.70–1.53) |
Current smoking | 1.16 (0.85–1.58) | 0.84 (0.65–1.10) | 2.01 (1.25–3.25) |
Ejection fraction, per 5% greater | 0.85 (0.81–0.91) | 1.06 (1.00–1.12) | 0.98 (0.88–1.10) |
Note: Associations reflect sub-hazard ratios (95% confidence intervals) for each outcome, considering all other outcomes as competing risks, and adjusted for all variables shown in the table. Due to missing values detailed in Table 1, population size is 1384. Bold font indicates statistically significant values (p<0.05).
Abbreviations: eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; PCR, protein-creatinine ratio; BMI, body mass index; SBP, systolic blood pressure; CRIC, Chronic Renal Insufficiency Cohort; CVD, cardiovascular disease